Skip to main content
. 2024 Jan 29;4(2):816–827. doi: 10.1021/jacsau.3c00795

Figure 5.

Figure 5

Pharmacokinetics and safety analysis of DSARTC. (A) Biodistribution of DSARTC at different time points in CWR22RV1 xenograft models. (B) Comparison of biodistribution between free peptide and DSARTC in CWR22RV1 xenograft models. (C) Plasma concentration–time curve analysis of DSARTC and ARTC. (D) Acute toxicity analysis of DSARTC.